Data processing: artificial intelligence – Miscellaneous
Reexamination Certificate
2011-04-12
2011-04-12
Sparks, Donald (Department: 2129)
Data processing: artificial intelligence
Miscellaneous
C424S010100, C706S924000
Reexamination Certificate
active
07925612
ABSTRACT:
An enhanced method for displaying assessment and analysis of risks of adverse effects resulting from use of at least one substance of interest, comprising: identifying the at least one substance of interest; selecting a profile related to the safety of the at least one substance of interest, using at least one filter; analyzing the risks of adverse effects resulting from the use of the at least one substance of interest using at least one data mining engine; and displaying the results of the analysis of risks of adverse effects in a format that permits perception of correlations. Such a format is preferably at least one format selected from the group consisting of a radar display for display of correlations, a sortable table, and a sortable line listing and where the format contains elements linked to data regarding the adverse effects.
REFERENCES:
patent: 4384329 (1983-05-01), Rosenbaum et al.
patent: 5299121 (1994-03-01), Brill et al.
patent: 5337919 (1994-08-01), Spaulding et al.
patent: 5371807 (1994-12-01), Register et al.
patent: 5495604 (1996-02-01), Harding et al.
patent: 5502576 (1996-03-01), Ramsay et al.
patent: 5583758 (1996-12-01), McIlroy et al.
patent: 5592668 (1997-01-01), Harding et al.
patent: 5594637 (1997-01-01), Eisenberg et al.
patent: 5634053 (1997-05-01), Noble et al.
patent: 5642731 (1997-07-01), Kehr
patent: 5659731 (1997-08-01), Gustafson
patent: 5664109 (1997-09-01), Johnson et al.
patent: 5692171 (1997-11-01), Andres
patent: 5737539 (1998-04-01), Edelson et al.
patent: 5758095 (1998-05-01), Albaum et al.
patent: 5804803 (1998-09-01), Cragun et al.
patent: 5833599 (1998-11-01), Schrier et al.
patent: 5845255 (1998-12-01), Mayaud
patent: 5860917 (1999-01-01), Comanor et al.
patent: 5864789 (1999-01-01), Lieberman et al.
patent: 5911132 (1999-06-01), Sloane
patent: 5924074 (1999-07-01), Evans
patent: 5978804 (1999-11-01), Dietzman
patent: 5991729 (1999-11-01), Barry et al.
patent: 6000828 (1999-12-01), Leet
patent: 6014631 (2000-01-01), Teagarden et al.
patent: 6054268 (2000-04-01), Perlin
patent: 6055538 (2000-04-01), Kessenich et al.
patent: 6067524 (2000-05-01), Byerly et al.
patent: 6076083 (2000-06-01), Baker
patent: 6076088 (2000-06-01), Paik et al.
patent: 6082776 (2000-07-01), Feinberg
patent: 6092072 (2000-07-01), Guha et al.
patent: 6098062 (2000-08-01), Janssen
patent: 6108635 (2000-08-01), Herren et al.
patent: 6112182 (2000-08-01), Akers et al.
patent: 6120443 (2000-09-01), Cohen-Laroque
patent: 6128620 (2000-10-01), Pissanons et al.
patent: 6137911 (2000-10-01), Zhilyaev
patent: 6151581 (2000-11-01), Kraftson et al.
patent: 6188988 (2001-02-01), Barry et al.
patent: 6209004 (2001-03-01), Taylor
patent: 6219674 (2001-04-01), Classen
patent: 6226564 (2001-05-01), Stuart
patent: 6246975 (2001-06-01), Rivonelli et al.
patent: 6253169 (2001-06-01), Apte et al.
patent: 6263329 (2001-07-01), Evans
patent: 6273854 (2001-08-01), Kane et al.
patent: 6317719 (2001-11-01), Schrier et al.
patent: 6331138 (2001-12-01), Witters et al.
patent: 6421665 (2002-07-01), Brye et al.
patent: 6446081 (2002-09-01), Preston
patent: 6466923 (2002-10-01), Young
patent: 6507829 (2003-01-01), Richards et al.
patent: 6542902 (2003-04-01), Dulong et al.
patent: 6578003 (2003-06-01), Carmada et al.
patent: 6658396 (2003-12-01), Tang et al.
patent: 6684221 (2004-01-01), Rejndrup
patent: 6697783 (2004-02-01), Brinkman et al.
patent: 6778994 (2004-08-01), Gogolak
patent: 6789091 (2004-09-01), Gogolak
patent: 6876966 (2005-04-01), Deng et al.
patent: 6950755 (2005-09-01), Stahl
patent: 7461006 (2008-12-01), Gogolak
patent: 7539684 (2009-05-01), Gogolak et al.
patent: 7542961 (2009-06-01), Gogolak
patent: 2001/0049673 (2001-12-01), Dulong et al.
patent: 2002/0010595 (2002-01-01), Kapp
patent: 2002/0040282 (2002-04-01), Bailey et al.
patent: 2002/0073042 (2002-06-01), Maritzen et al.
patent: 2002/0120350 (2002-08-01), Klass et al.
patent: 2002/0129031 (2002-09-01), Lau et al.
patent: 2002/0142815 (2002-10-01), Candelore
patent: 2002/0169771 (2002-11-01), Melmon et al.
patent: 2002/0183965 (2002-12-01), Gogolak
patent: 2003/0040662 (2003-02-01), Keys
patent: 2003/0124514 (2003-07-01), Vingerhoets et al.
patent: 2004/0010511 (2004-01-01), Gogolak et al.
patent: 2004/0015372 (2004-01-01), Bergman et al.
patent: 2004/0030503 (2004-02-01), Arouh et al.
patent: 2009/0076847 (2009-03-01), Gogolak
patent: 10-225500 (1998-08-01), None
patent: 11-282934 (1999-10-01), None
Szarfman, Ana, M.D., Ph.D., “New Methods for Signal Detection,” Proceedings of the 15th International Conference on Pharmacoepidemiology, 56 pp., Aug. 28, 1999.
Multum Trusted Health Information [online], [retrieved on Aug. 22, 2002], 1 p., Retrieved from the Internet: http://www.multum.com.
Epocrates [online], Copyright 2002 [retrieved on Aug. 22, 2002], 1 p., Retrieved from the Internet: http://www.epocrates.com.
PDR.net [online], Copyright 2002 [retrieved on Aug. 22, 2002], 1 p., Retrieved from the Internet: http//www.pdr.net/HomePage—template.jdp.
Szarfman, Ana, M.D., Ph.D., “Application of Screening Algorithms and Computer Systems to Efficiently Signal Combinations of Drugs and Events in FDA's Spontaneous Reports” [online], Oct. 22, 2001, 2 pp., Retrieved from the Internet: http://apha.confex.com/apha/129.am/techprogram/paper—32272.
“Vaccine Adverse Event Reporting System (VAERS)” [online], U.S. Department of Health and Human Services, Jul. 2001 [retrieved Jul., 2001], 12 pp., Retrieved from the Internet: http://www.vaers.org/search/README.
Andrews, Michelle, “Prescription for Disaster,”SmartMoney, pp. 124-129, May 2001.
Mootrey, Gina, et al., “Chapter 18: Surveillance for Adverse Events Following Vaccination,”VPD Surveillance Manual, 20 pp., 1999.
Szarfman, Ana, M.D., Ph.D., “New Methods for Signal Detection,”Proceedings of the 15thInternational Conference on Pharmacoepidemiology, 56 pp., Aug. 28, 1999.
DuMouchel, William, “Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System,”The American Statistician, vol. 53, No. 3., 31 pp., Apr. 1999.
“The Totally Unauthorized, Completely Repudiated, Bootlegged, Unsupported, Undocumented, Insider's Post-Pre-Alpha Guide to Multum's Lexicon,” Multum Information Services, Inc., pp. 1-49, Copyright 1997-1999, Apr. 12, 1999 (Rev. 3.d).
“Post-Marketing Surveillance for Adverse Events After Vaccination: The National Vaccine Adverse Event Reporting System (VAERS),”Medwatch, 12 pp., Nov. 1998.
“Multum Releases Web-Based MediSource Lexicon; Downloadable Drug Product and Disease Listings Database,”PR Newswire, 2 pp., Apr. 10, 1997.
Lipschutz, Seymour, Ph.D., “Theory and Problems of Linear Algebra,” Schaum's Outline Series, McGraw-Hill Book Company, 5 pp., 1968.
Anderson, T. W., “A Bibliography of Multivariate Statistical Analysis,” Oliver & Boyd, Edinburgh, 3 pp., 1972.
Darlington, Richard B., “Regression and Linear Models,” McGraw-Hill Publishing Company, 15 pp., 1990.
Press, James S. and Wilson, Sandra, “Choosing Between Logistic Regression and Discriminant Analysis,”Journal of the American Statistical Association, vol. 73, pp. 699-705, Dec. 1978.
Kosko, Bart, “Neural Networks and Fuzzy Systems—A Dynamical Systems Approach to Machine Intelligence,” Prentice Hall, Englewood Cliffs, NJ, 11 pp.,1992.
International Search Report for Application No. PCT/US02/13666, dated Jul. 16, 2002 (mailing date).
International Search Report for Application No. PCT/US02/13662, dated Jul. 15, 2002 (mailing date).
Doyle, C. D. (1994)Microsoft Press Computer Dictionary Second Edition: The Comprehensive Standard for Business, School, Library and Home. Microsoft Press:122, 147, 240, 348, 366-367, 383.
Vesell, E. S., (2000).“Advances in Phamacogenetics and Pharmacogenomics,”Journal of Clinical Pharmacology. 40:930-938.
Caraco, Y., (1998).“Genetic Determinants of Drug Responsiveness and Drug Interactio
Buss Benjamin
Davis Peter J.
Sparks Donald
Whiteford Taylor & Preston LLP
LandOfFree
Method for graphically depicting drug adverse effect risks does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for graphically depicting drug adverse effect risks, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for graphically depicting drug adverse effect risks will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2714834